Chronoscale plans to divest Ekso Bionics, focus on cloud business

EKSO BIONICS HOLDINGS, INC.

Board committed on May 29, 2026 to divest wholly owned subsidiary Ekso Bionics, Inc.
Company will focus solely on cloud business; expects divestiture completion in first fiscal quarter.
Material charges expected: severance, lease termination, transaction costs; estimate not yet available.
Company will amend 8-K with cost estimates within four business days as required.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.